Pyrazolo[5,1b]oxazole derivatives as CRF-1 receptor antagonists
申请人:Novartis AG
公开号:US08163785B2
公开(公告)日:2012-04-24
There are described 4-difluoromethoxyphenyl pyrazolo[5.1-b]oxazole derivatives of Formula I:
which are useful as corticotropin releasing factor (CRF) receptor antagonists and as pharmaceuticals.